Joshua Lehrer-Graiwer
Chief Medical Officer, Global Blood Therapeutics, Inc.
Companies
- Caladrius BiosciencesChief operating officer Sep 28, 2026 to now1
- Caladrius BiosciencesPresident Sep 28, 2026 to now1
- Fulcrum Therapeutics (United States)Board member May 1, 2026 to now2
- LENZ Therapeutics, Inc.Board member Jun 24, 2021 to Feb 23, 20233
- LENZ Therapeutics, Inc.Chief executive officer Jun 24, 2021 to Feb 23, 20233
- LENZ Therapeutics, Inc.President Jun 24, 2021 to Feb 23, 20233
- Global Blood Therapeutics, Inc.Chief Medical Officer Oct 3, 2019 to Mar 9, 20204
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Caladrius Biosciences LSTA27,808 shares5$27.3K at $0.98Sep 28, 2026
- Fulcrum Therapeutics (United States) FULC0 shares6May 1, 2026
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6